Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children

Annals of Saudi Medicine

Volumn 24, Issue 1, 2004, Pages 27-30

  Al Salloum, Abdullah A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Children; Focal segmental glomerulosclerosis; Nephrotic syndrome; Pulse cyclophosphamide; Steroid resistance

Indexed keywords

ALKYLATING AGENT; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; MESNA; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ALOPECIA; ARTICLE; CATARACT; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOSE RESPONSE; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; FOCAL GLOMERULONEPHRITIS; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LEUKOPENIA; MALE; NAUSEA AND VOMITING; NEPHRITIS; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

EID: 1042269494     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.27     Document Type: Article

References (16)

1. Warady BA, Hebert D, Sullivan KE, Alexander SR, Tegani A. Renal transplantation, chronic dialysis and chronic renal insufficiency in children and adolescents. The 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1997;11:49-64.
2. Ichikawa I, Fogo A. Focal Segmental Glomerulosclerosis. Pediatr Nephrol. 1996;10:374-391.
3. Mendoza S, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol. 1990;4:303.
4. Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis. 1994;23: 773-783.
5. Tarshish P, Tobin JN, Bernstein J, Edelmann JR. CM cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the international study of kidney diseases in children. Pediatr Nephrol. 1996; 10: 590-593.
6. Vehaskari VM. Treatment practices of FSGS among Northern American Pediatric Nephrologist Pediatr Nephrol. 1999;13: 301-303.
7. Tune BM, Lieberman E, Mendoza SA (1996). Steroid resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol. 1996;10: 772-778.
8. Aviles DH, Irwin KC, Dublin LS, Vehaskari VM. Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol. 1996;13: 298-300.
9. Geary DF, Favine M, Thorner P, Baumal R. Response to cyclophosphamide in steroid resistant focal segmental glomeruloclerosis: a reappraisal. Clin Nephrol. 1984; 22: 109-113.
10. Gulati S, Pokhariyal S, Sharma RK, Elhence R, Kher V, Pandey CM, Gupta A. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome. Nehprol Dial Transplant. 2001;16: 2013-2017.
11. Austin HA, Klippel JH, Balow JE, Le Riche NG, Steinberg AD, Plotz PH, Decken JL. Therapy of lupus nephritis controlled trial of prednisolone and cytotoxic drugs. N Engl J Med. 1986;314: 614-619.
12. Martin F, Lanwerys B, Lefbuz C, Devogelair JP, Houssain FA. Side effects of intravenous cyclophosphamide pulse. Therap Lupus. 1997;6: 254-257.
13. Haubitz M, Ehlerding C, Kamino A, Koch KM, Brunkhorst R. Reduced gonadal toxicity after IV cyclophosphamide administration in patients with non malignant disease. Clin Nephrol. 1988;49: 19-23.
14. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK. Intravenous pulse cyclophosphamide: a new regimen for steroid resistant minimal change nephrotic syndrome. Pediatr Nephrol. 1994;8: 1-3.
15. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am. 1987; 34: 571-590.
16. Rennert WP, Kulu UK, Jacobs D, Goetsch S, Verhaart S. Pulse cyclophosphamide for steroid resistant focal segmental glomerulosclerosis. Pediatr Nephrol. 1999;13:113-116.